CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

Prospective oberservational registryWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (1)

Name (Synonyms) Correlation
drug187 Anti-Sars-CoV-2 Convalescent Plasma Wiki 1.00

Correlated MeSH Terms (2)

Name (Synonyms) Correlation
D045169 Severe Acute Respiratory Syndrome NIH 0.05
D018352 Coronavirus Infections NIH 0.04

Correlated HPO Terms (0)

Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials

1 COVID-19 Registry Rhineland-Palatinate (Germany) - COVID-19 Disease Registry a National, Multicentre, Non-interventional, Prospective Observational Study

Documentation of all patients undergoing inpatient treatment for SARS-CoV-2 infection with regard to clinical status at admission, medical history, inpatient treatment and course of disease. The aim is to create a risk stratification of the infection on the basis of clinical data as well as therapy and disease progression of the patients. This may also contribute to a better planning of resources.

NCT04335188 COVID Other: Prospective oberservational registry

Primary Outcomes

Description: presence of infiltrates

Measure: Chest x-ray

Time: throughout study completion, in average 1.5 years

Description: presence of infiltrates

Measure: Chest CT

Time: throughout study completion, in average 1.5 years

Description: number of patients with ICU treatment required

Measure: Supportive care - ICU

Time: throughout study completion, in average 1.5 years

Description: number of patients with oxygen therapy required

Measure: Supportive care - oxygen therapy

Time: throughout study completion, in average 1.5 years

Description: number of patients with ventilation required

Measure: Supportive care - ventilation

Time: throughout study completion, in average 1.5 years

Description: number of patients with medication changes

Measure: Medication

Time: throughout study completion, in average 1.5 years

Description: number of patients with ECMO required

Measure: Therapeutic strategies

Time: throughout study completion, in average 1.5 years

Description: number of patients with significant changes in lab parameters

Measure: Lab parameters

Time: throughout study completion, in average 1.5 years

Description: number of patients with complications during hospital stay

Measure: Intra-hospital complications

Time: throughout study completion, in average 1.5 years

Description: vital status at discharge: alive, dead

Measure: Vital status at discharge

Time: throughout study completion, in average 1.5 years

No related HPO nodes (Using clinical trials)